Arbutus Biopharma ABUS
NASDAQ ABUS
$4.69 -0.17 (-3.50%)
At close: Sep 29, 2026 · 4:00 PM EDT

Arbutus Biopharma (ABUS) Deferred Taxes (2015 - 2019)

Updated

Arbutus Biopharma's Deferred Taxes came in at -$12.66 million for FY2019, compared with -$4.28 million in FY2018.

Analysis

Arbutus Biopharma (ABUS) Deferred Taxes (2015 - 2019) Analysis & Trends

Going back to FY2015, Arbutus Biopharma's Deferred Taxes data covers 5 years.

  • The five-year range for annual Deferred Taxes is -$105.06 million (FY2016) to -$4.28 million (FY2018).
  • Per Business Quant, earlier years put Deferred Taxes at -$4.28 million in FY2018, -$24.32 million in FY2017, -$105.06 million in FY2016 and -$16.19 million in FY2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -479.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -195.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -544.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -398.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -291.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -587.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -1.32 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Arbutus Biopharma 960.50 Mn 587.48 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 -12.66 Mn
Sep 30, 2018 -4.28 Mn
Dec 31, 2017 -24.32 Mn
Dec 31, 2016 -40.20 Mn
Jun 30, 2016 -64.86 Mn
Dec 31, 2015 -989,000.00
Sep 30, 2015 -15.20 Mn
API Access

Arbutus Biopharma Deferred Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=deferred-taxes&ticker=ABUS&period=max&api_key=YOUR_API_KEY